<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D919426E-D132-4DE7-935C-0D9938659194"><gtr:id>D919426E-D132-4DE7-935C-0D9938659194</gtr:id><gtr:name>University of Illinois at Chicago</gtr:name><gtr:address><gtr:line1>University of Illinois at Chicago</gtr:line1><gtr:line2>1200 West Harrison</gtr:line2><gtr:line4>Chicago</gtr:line4><gtr:line5>Illinois</gtr:line5><gtr:postCode>60607-7161</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Pharmacology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D919426E-D132-4DE7-935C-0D9938659194"><gtr:id>D919426E-D132-4DE7-935C-0D9938659194</gtr:id><gtr:name>University of Illinois at Chicago</gtr:name><gtr:address><gtr:line1>University of Illinois at Chicago</gtr:line1><gtr:line2>1200 West Harrison</gtr:line2><gtr:line4>Chicago</gtr:line4><gtr:line5>Illinois</gtr:line5><gtr:postCode>60607-7161</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F2C20A8A-B31E-4A1B-8E74-EB1F2EC5A830"><gtr:id>F2C20A8A-B31E-4A1B-8E74-EB1F2EC5A830</gtr:id><gtr:firstName>Ming</gtr:firstName><gtr:surname>Lei</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DDED68AB-EBB4-4AC4-B80E-803DC0952562"><gtr:id>DDED68AB-EBB4-4AC4-B80E-803DC0952562</gtr:id><gtr:firstName>Xin</gtr:firstName><gtr:surname>Wang</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1002647"><gtr:id>787BF99B-8404-4204-A8A1-44FA5749EC64</gtr:id><gtr:title>Cardiac electrical function, Ca2+ sensitivity and arrhythmogenesis in mice with genetic modifications of Pak1</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1002647</gtr:grantReference><gtr:abstractText>Heart disease remains the prime killer in the western world. In the UK, heart disease kills 175,000 people every year and 2.6 million people live with debilitating heart conditions. More than 50% of deaths from heart diseases result from cardiac arrhythmias at a total annual national cost of treatment of #~1.6 billion. 

The main rationale and motivation of our research is to improve treatment of cardiac rhythm disorders. Current therapies are highly unsatisfactory. Our experiments test a new direction in potential treatment strategies. We have discovered that an enzyme called P21-activated kinase1 (Pak1) is able to chemically modify the elements in heart cells responsible for the rate and rhythm of the heart beat. Our project will take these findings to the next essential level, i.e. understanding the function of Pak1 in intact beating hearts. Our approaches involving enhancing or disabling the function of Pak1 and determining the outcome of these modification on the generation of altered heart rythm mimicking electrical disorders in the human heart. This project is pivotal for understanding of regulatory mechanisms for cardiac electrical and contractile functions and will provide information essential to the development of new treatments for cardiac rhythm disorders.</gtr:abstractText><gtr:technicalSummary>Cardiac electrical function is highly regulated on a beat to beat basis by multiple extra- and intra-cellular signalling pathways through control of the activity of the ion channels across the membrane of the heart cells. How such regulation is designed to maintain normal cardiac function under broad physiological conditions and how it comes into play in the face of disease conditions are important issues to be addressed. Our recent studies indicate a novel role of P21 activated kinase-1 (Pak1) in regulating cardiac electrical and contractile functions. The proposed project thereby aims to further clarify the mechanisms underlying the critical roles of Pak1 in regulating cardiac electrical function, myofilament Ca2+ sensitivity and ventricular arrhythmogenesis using mice with genetic modifications of Pak1. The physiological consequences of targeted modifications will then be investigated at the cellular, tissue, whole heart and organism levels. Multi-disciplinary approaches including in vivo physiology, mechanics, electrophysiology and molecular biology will be used. The work will shed light on a major area of uncertainty in cardiac regulation and directly lead to new therapeutic strategies directed at human cardiac arrhythmic disease.</gtr:technicalSummary><gtr:fund><gtr:end>2015-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>743885</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Anatomy and Genetics</gtr:department><gtr:description>Pak1 signalling in the heart</gtr:description><gtr:id>BC6FD429-A161-484C-886D-0A3FEBC8F9CF</gtr:id><gtr:impact>A number of joint papers have been published and as a lead PI, we have been awarded a joint BHF project grant</gtr:impact><gtr:partnerContribution>see above</gtr:partnerContribution><gtr:piContribution>A number of joint papers have been published and as a lead PI, we have been awarded a joint BHF project grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Illinois at Chicago (UIC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Pak1 signalling in the heart</gtr:description><gtr:id>292DB8D0-1E91-4377-8E50-C1770D1EFF79</gtr:id><gtr:impact>joint papers and a joint grant</gtr:impact><gtr:partnerContribution>a number joint papers</gtr:partnerContribution><gtr:piContribution>Have published numerous joint original and review papers and obtained a joint MRC project grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>The 5th Ion Channel Conference (Luzhou, China)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>97F6D3F9-36C6-4E71-82D7-CC6B231AF7F7</gtr:id><gtr:impact>A keynote talk on novel cardiac protective role in the heart</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keynote talk at 2013 XXI ISHR Congress in San Diego</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>86F3555D-AF34-4D81-B511-525E194345C6</gtr:id><gtr:impact>talk sparked questions and discussion afterwards

further information and collaboration are requested by the audience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>conference talk (The Chinese Association for Physiological Sciences, The Physiological Society and six other international Physiological Societies, Suzhou, China. 1-4th Nov 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>90A6FCDD-5FEC-40A7-8A4F-3D6DB52FA2D4</gtr:id><gtr:impact>talk sparked questions and discussion afterwards

after my talk, further request of the information is requested by the organiser and audience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>media interest</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9E1F54CD-8726-488E-9134-D1BEBAB4816E</gtr:id><gtr:impact>Together with my collaborator Prof. H Zhang, we have disseminated via the Press Office of the University of Manchester their research work on the mechanistic link between Scn5a gene mutations and impaired cardiac pacemaker function. This was covered widely by the national and international media, that includes BBC One (6th July 2010, North West Tonight (22:25 pm)).

a major impact in public about disease understanding</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University visit (Center for Cellular and Molecular Arrhythmia Research Program, University of Wisconsin School of Medicine and Public Health, USA)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E7480B50-CB55-4AF7-BAC4-DFCF22276A60</gtr:id><gtr:impact>Talk sparked questions and discussion afterwards

further request for the information of the research by the audience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference keynote talk (at the Shanghai International Ion Channel conference, Shanghai, China. 20th July 2011)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7B6C9299-50FA-4E5C-A867-571FADC79B15</gtr:id><gtr:impact>talk sparked questions and discussion afterwards

further information was requested by the audience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conferecne Keynote talk (at Cardiac &amp; Respiratory Physiology Themed Meeting, The Physiological Society. Manchester, UK. 4th-6th Sept 2012)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6671D41E-A388-4922-8664-348061B19934</gtr:id><gtr:impact>talk sparked questions and discussion afterwards

further information was requestion by the audience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>hosptial visit (First Hospital, Beijing University, P. R. of China</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8DEBD20C-4BCE-4C06-8FD7-B370DA61775F</gtr:id><gtr:impact>talk stimulated discussion and questions afterwards

after my talk, the hopital asked for further inforamtion of the research and collaboration.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference talk (Annual Conference of Australia Physiological Society)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1C9D8A26-3F34-4579-8B2D-942E1EA2AC7E</gtr:id><gtr:impact>talk sparked questions and discussion afterwards

further information is requested by the audience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University visit (Verona, Italy)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AD68853C-6ACA-4368-848B-1B04662DD5BC</gtr:id><gtr:impact>talk sparked questions and discussions afterwards

discussion by the audience about new treatment for the patients based on our research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>new treatment for cardiac hypertrophy and heart failure</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>1D42603F-E5B6-4833-B9CC-98E16AFFDB07</gtr:id><gtr:impact>Our novel recent findings on Pak1 as a novel therapeutic target for cardiac hypertrophy and heart failure (published in Circulation, Circulation Heart Failure, Circulation, Arrhythm Electrophysiol, the top journals in cardiovascular field) have attracted wide attention in the field. Several cardiologists have approached us for collaboration in developing new therapy based on our findings on Pak1. A phase 2 clinical trials on FTY720, a non-selective Pak1 activator is under planning. In London.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A mouse model carrying a cardiomyocyte-restricted deletion of Pak1 (Pak1CKO).</gtr:description><gtr:id>5C4AC85A-7474-414D-9934-C2C1C79B3CB2</gtr:id><gtr:impact>Pak1 is a key member of a highly conserved family of serine-threonine protein kinases (Pak family) regulated by the small Ras-related G proteins, Cdc42 and Rac1. We have recently established and are currently testing a mechanistic hypothesis that the Pak1 regulatory pathway is central to the regulation of cardiac excitation and contraction (Ke et al Circ 2007; 73:729). We then went on to demonstrate that Pak1 activation prevents cardiac ischemic/reperfusion injury and its associated arrhythmias, findings reported in a series of leading cardiovascular journals including J Mol Cell Cardiol (2010; 48: 406) and Am J Physiol (Heart Circ Physiol) (2011,301:H1487). Finally, we have identified a critical role for Pak1 in preventing ventricular arrhythmias associated with cardiac hypertrophy and stress though regulating Ca2+ handling in ventricular myocytes. We are preparing a full paper in this area for a top journal in the cardiovascular field. This series of studies culminated in a recent Circulation paper (2011; 124:2702) that proposed a novel role for Pak1 as a critical signalling hub in cardioprotection, which limits excessive hypertrophic remodelling. This would act at a site downstream of Cdc42 thereby conveying both anti-hypertrophic and survival signals to the JNK pathway in cardiomyocytes.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>A mouse model carrying a cardiomyocyte-restricted deletion of Pak1 (Pak1CKO).</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32CAC2AB-75BF-494C-A0F9-791703F96DFC"><gtr:id>32CAC2AB-75BF-494C-A0F9-791703F96DFC</gtr:id><gtr:title>Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/04d8ccafc2aba0efed97f575265523a8"><gtr:id>04d8ccafc2aba0efed97f575265523a8</gtr:id><gtr:otherNames>Egom EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA206AF6-EB37-4B89-BC97-0B98ADED6ED4"><gtr:id>BA206AF6-EB37-4B89-BC97-0B98ADED6ED4</gtr:id><gtr:title>The SCN5A mutation A1180V is associated with electrocardiographic features of LQT3.</gtr:title><gtr:parentPublicationTitle>Pediatric cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0172-0643</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2EF1D625-7C0B-45A6-92CF-546767CCD681"><gtr:id>2EF1D625-7C0B-45A6-92CF-546767CCD681</gtr:id><gtr:title>Regulation of Ca(2+) transient by PP2A in normal and failing heart.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a84104b0647a13025b04a2f120a8608"><gtr:id>3a84104b0647a13025b04a2f120a8608</gtr:id><gtr:otherNames>Lei M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4E0B0FC3-3204-4198-8D1C-D8DDA7047E31"><gtr:id>4E0B0FC3-3204-4198-8D1C-D8DDA7047E31</gtr:id><gtr:title>Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2e3a8196ea0d9c6214159e5e16fd2a38"><gtr:id>2e3a8196ea0d9c6214159e5e16fd2a38</gtr:id><gtr:otherNames>Tsui H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9A5FD71-AEFD-4813-B835-292EB7ED7943"><gtr:id>E9A5FD71-AEFD-4813-B835-292EB7ED7943</gtr:id><gtr:title>A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.</gtr:title><gtr:parentPublicationTitle>Circulation. Heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c14bc14b523f46259b756e82875d7f82"><gtr:id>c14bc14b523f46259b756e82875d7f82</gtr:id><gtr:otherNames>Liu W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1941-3289</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0AF4C9E2-F127-4D35-BB05-2CD1A8CBEAF6"><gtr:id>0AF4C9E2-F127-4D35-BB05-2CD1A8CBEAF6</gtr:id><gtr:title>Novel insights into mechanisms for Pak1-mediated regulation of cardiac Ca(2+) homeostasis.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E292B3FA-B2D0-45D8-AD99-72B12BA0EBE4"><gtr:id>E292B3FA-B2D0-45D8-AD99-72B12BA0EBE4</gtr:id><gtr:title>Role of Pak1 signalling in cardiac regulation and its therapeutic potential in heart disease</gtr:title><gtr:parentPublicationTitle>International Conference of Physiological Sciences joint conference Proceeding</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a84104b0647a13025b04a2f120a8608"><gtr:id>3a84104b0647a13025b04a2f120a8608</gtr:id><gtr:otherNames>Lei M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F6AA80F8-522D-4958-BDD5-30B08F54A957"><gtr:id>F6AA80F8-522D-4958-BDD5-30B08F54A957</gtr:id><gtr:title>Effect of sphingosine-1-phosphate on L-type calcium current and Ca(2+) transient in rat ventricular myocytes.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/04d8ccafc2aba0efed97f575265523a8"><gtr:id>04d8ccafc2aba0efed97f575265523a8</gtr:id><gtr:otherNames>Egom EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-8177</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3439FB70-DB9F-4D8E-8694-A10BF88B13A8"><gtr:id>3439FB70-DB9F-4D8E-8694-A10BF88B13A8</gtr:id><gtr:title>A p21 activated kinase activating peptide antagonizes angiotensin II-induced ventricular hypertrophy and fibrosis.</gtr:title><gtr:parentPublicationTitle>Cardiovasc Res</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0464da27d0309505544cd1a53d9dfff2"><gtr:id>0464da27d0309505544cd1a53d9dfff2</gtr:id><gtr:otherNames>Ke YB</gtr:otherNames></gtr:author></gtr:authors></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F030DBDD-938A-4801-8556-A326C18574AF"><gtr:id>F030DBDD-938A-4801-8556-A326C18574AF</gtr:id><gtr:title>Regulation of Ca(2+) transient by PP2A in normal and failing heart.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a84104b0647a13025b04a2f120a8608"><gtr:id>3a84104b0647a13025b04a2f120a8608</gtr:id><gtr:otherNames>Lei M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DC9CB7A3-4E63-4F62-B687-0307CA59A3B6"><gtr:id>DC9CB7A3-4E63-4F62-B687-0307CA59A3B6</gtr:id><gtr:title>Novel insights into mechanisms for Pak1-mediated regulation of cardiac Ca(2+) homeostasis.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D47AAA64-C6EB-43AC-BF76-F2E4F657A1D8"><gtr:id>D47AAA64-C6EB-43AC-BF76-F2E4F657A1D8</gtr:id><gtr:title>P21 activated kinase-1 in cardiac automaticity and excitability regulation and its therapeutic potential in cardiac arrhythmias</gtr:title><gtr:parentPublicationTitle>2013 XXI ISHR Congress proceeding</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a84104b0647a13025b04a2f120a8608"><gtr:id>3a84104b0647a13025b04a2f120a8608</gtr:id><gtr:otherNames>Lei M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9D14D061-B657-4247-ABB4-C6C841BB0868"><gtr:id>9D14D061-B657-4247-ABB4-C6C841BB0868</gtr:id><gtr:title>PAK1 is a novel cardiac protective signaling molecule.</gtr:title><gtr:parentPublicationTitle>Frontiers of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ded3490cbc366002471126ec4c3c3693"><gtr:id>ded3490cbc366002471126ec4c3c3693</gtr:id><gtr:otherNames>Ke Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2095-0217</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/80EF1835-FCF8-4DEA-8610-27DF2A99518C"><gtr:id>80EF1835-FCF8-4DEA-8610-27DF2A99518C</gtr:id><gtr:title>Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c3205ec97d8c1babf514ac42bf10dda"><gtr:id>2c3205ec97d8c1babf514ac42bf10dda</gtr:id><gtr:otherNames>Davies L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FFFBE892-EDA4-4AEE-B1C1-1340D1DFD0AD"><gtr:id>FFFBE892-EDA4-4AEE-B1C1-1340D1DFD0AD</gtr:id><gtr:title>Pathophysiological Mechanisms of Sino-Atrial Dysfunction and Ventricular Conduction Disease Associated with SCN5A Deficiency: Insights from Mouse Models.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6b89cd909004e1ac07fb1ab74d2c10d3"><gtr:id>6b89cd909004e1ac07fb1ab74d2c10d3</gtr:id><gtr:otherNames>Huang CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8D84FF72-BA84-4FDC-B76F-7B75CEB9501E"><gtr:id>8D84FF72-BA84-4FDC-B76F-7B75CEB9501E</gtr:id><gtr:title>Growth factors mediated differentiation of mesenchymal stem cells to cardiac polymicrotissue using hanging drop and bioreactor.</gtr:title><gtr:parentPublicationTitle>Cell biology international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/875fc23a91529eda79fcc5ce3afb651f"><gtr:id>875fc23a91529eda79fcc5ce3afb651f</gtr:id><gtr:otherNames>Konstantinou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1065-6995</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/84FE96A2-4533-4D12-B6D5-83D4D844CF01"><gtr:id>84FE96A2-4533-4D12-B6D5-83D4D844CF01</gtr:id><gtr:title>Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/- hearts.</gtr:title><gtr:parentPublicationTitle>Acta physiologica (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1748-1708</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/91A0B5D5-E4FB-448F-AF3C-34FF11F16ECD"><gtr:id>91A0B5D5-E4FB-448F-AF3C-34FF11F16ECD</gtr:id><gtr:title>Pak1 is required to maintain ventricular Ca&amp;sup2;? homeostasis and electrophysiological stability through SERCA2a regulation in mice.</gtr:title><gtr:parentPublicationTitle>Circulation. Arrhythmia and electrophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1941-3084</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC4D220C-2139-46C1-8603-7F85C86E2A3A"><gtr:id>EC4D220C-2139-46C1-8603-7F85C86E2A3A</gtr:id><gtr:title>Conduction slowing contributes to spontaneous ventricular arrhythmias in intrinsically active murine RyR2-P2328S hearts.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular electrophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1045-3873</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/47D61E29-469F-49FF-9548-2A78D5E6F2AC"><gtr:id>47D61E29-469F-49FF-9548-2A78D5E6F2AC</gtr:id><gtr:title>Optogenetic Control of Heart Rhythm by Selective Stimulation of Cardiomyocytes Derived from Pnmt(+) Cells in Murine Heart.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8D3DB342-3BD9-4DF3-91E9-FEA2F3D96103"><gtr:id>8D3DB342-3BD9-4DF3-91E9-FEA2F3D96103</gtr:id><gtr:title>Novel roles of PAK1 in the heart.</gtr:title><gtr:parentPublicationTitle>Cellular logistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ded3490cbc366002471126ec4c3c3693"><gtr:id>ded3490cbc366002471126ec4c3c3693</gtr:id><gtr:otherNames>Ke Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2159-2780</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63AEF9BE-B4BB-41A8-8D29-E7228D46ED93"><gtr:id>63AEF9BE-B4BB-41A8-8D29-E7228D46ED93</gtr:id><gtr:title>PAK1 is a novel cardiac protective signaling molecule.</gtr:title><gtr:parentPublicationTitle>Frontiers of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ded3490cbc366002471126ec4c3c3693"><gtr:id>ded3490cbc366002471126ec4c3c3693</gtr:id><gtr:otherNames>Ke Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2095-0217</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002647</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>